ClinicalTrials.Veeva

Menu

Effects of Slow Breathing on Blood Pressure and Autonomic Function

F

Fundação de Amparo à Pesquisa do Estado de São Paulo

Status and phase

Completed
Phase 4

Conditions

Hypertension

Treatments

Device: Device-guided breathing (Resperate - InterCure, Israel)
Other: Listen music

Study type

Interventional

Funder types

Other

Identifiers

NCT01390727
FAPESP 2010/06921-2

Details and patient eligibility

About

Hypertension is a chronic disease that affects about 23% of the brazilian population. The treatment of hypertension by pharmacological intervention is efficacious, but has side effects and significant costs. Techniques that reduce the respiratory rate are shown as a effective non-pharmacological treatment in controlling blood pressure. Evidence has shown that a slow and deep breathing rate, around 10 breaths per minute or less, significantly reduces blood pressure. However, the physiological mechanisms involved in blood pressure decrease due to decreased respiratory rate are not yet known. Therefore the goals of this study will evaluate the chronic effect of breathing exercise guided on office and 24 hours blood pressure and analyse the chronic effect of breathing exercise guided over the autonomic function in hypertensive patients in stages 1 and 2.

Enrollment

32 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Hypertensive patients with or without use of antihypertensive drug therapy with office systolic blood pressure between 140 and 179 mmHg and / or office diastolic between 90 and 109mmHg).
  • Adults over 18 years.
  • Both genders.

Exclusion criteria

  • Use of medications that alter sympathetic nerve activity (beta blockers and / or sympatholytics).
  • Use of three or more classes of antihypertensive drugs
  • Secondary Hypertension
  • Chronic Respiratory Disease
  • Diabetes Mellitus.
  • Chronic Kidney Disease with Clearance Creatinine <60 ml/min
  • Congestive heart failure
  • Coronary disease
  • Pregnant
  • BMI > 30 kg/m2

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

32 participants in 2 patient groups, including a placebo group

Listen music
Placebo Comparator group
Description:
After randomization, the patients allocated in this arm will be instructed to listen to calm music for 15 minutes per day during 8 weeks
Treatment:
Other: Listen music
Device-guided breathing
Active Comparator group
Description:
After randomization, the patients allocated in this arm will be instructed to use a device-guided breathing, for 15 minutes per day during 8 weeks, with the aim to reduce the respiratory frequency to less than 10 breaths/min
Treatment:
Device: Device-guided breathing (Resperate - InterCure, Israel)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems